论文部分内容阅读
目的评价米非司酮序贯宫瘤宁治疗子宫肌瘤的临床效果。方法A组(观察组):口服米非司酮12.5mg,l次/d×3个月后序贯宫瘤宁6片/次,3次/d×3个月。B组(对照组)单独口服米非司酮,服药方法同A组。结果两组服用米非司酮期间均闭经,血红蛋白上升,瘤体平均体积均缩小,但A组远期复发率较B组明显降低,两组间差异有显著性(P<0.05)。结论米非司酮序贯宫瘤宁治疗子宫肌瘤是目前中西医结合治疗子宫肌瘤的一种优良方法。
Objective To evaluate the clinical efficacy of mifepristone sequential Mianyangning in treating uterine fibroids. Methods Group A (observation group): oral mifepristone 12.5mg, l times / d × 3 months after the order of palace tumor Ning 6 tablets / times, 3 times / d × 3 months. Group B (control group) mifepristone alone, medication method with the A group. Results During the course of mifepristone treatment, both amenorrhea and hemoglobin were ameliorated. The mean volume of tumor was reduced. However, the long-term relapse rate of group A was significantly lower than that of group B, with significant difference between the two groups (P <0.05). Conclusions Mifepristone sequential Mianyangning treatment of uterine fibroids is an excellent method for the treatment of uterine fibroids with integrated traditional Chinese and Western medicine.